Think your testosterone is low? What real diagnosis looks like

You think your testosterone is low because you have the symptoms: fatigue that sleep does not touch, a mood that flattened without a reason you can name and strength that used to come back after a rest day but now does not. You have also seen what the testosterone clinic down the street wants: an injection twice a week forever and a monthly bill that never ends. Both of those things are real. This page is about what sits between them.

Why the standard answer is either nothing or a subscription

If you have raised this with a conventional doctor, you probably got one of two answers. The first was a blood test, a number in the normal range and a dismissal, even though the number sat at the bottom of that range. The second was a referral nowhere, because the visit was eight minutes and fatigue has a hundred causes.

If you have looked at a men's clinic instead, you got the opposite. A diagnosis in one visit, an injection protocol and a lifetime subscription. That model has an incentive problem nobody hides anymore. The clinic's revenue is the prescription, so the prescription never ends and the labs that would justify stopping are the ones nobody orders.

Both answers have the same defect. Neither one measured enough to know. The standard system under-measures because it is paid to be brief. The clinic model over-prescribes because it is paid to be permanent. Our membership exists in the space between: measure enough to know, then prescribe the least medicine that gets you the most result.

What the Biomarker Audit changes

A testosterone level alone is not a diagnosis. The Cardiometabolic Optimization Panel measures nine biomarkers: Hs-CRP, Comprehensive Metabolic Panel, TSH With Reflex To Free T4, Fasting Insulin, Lipoprotein (A), Hemoglobin A1c (HbA1c), Lipid Panel, Standard, Apolipoprotein B (ApoB) and CBC (Includes Differential And Platelets). When there is a reason, your clinician can order more, such as LH, FSH, estradiol and SHBG, billed by the lab at its own rates. The reason is that low testosterone is sometimes the disease and sometimes the symptom. Sleep apnea, obesity, insulin resistance, thyroid dysfunction and certain medications can all depress it and treating the testosterone without addressing the cause is refilling a leaking tire.

The panel repeats every 90 days. That cadence is the difference between a prescription and a protocol. In the first quarter your clinician establishes the baseline and, if replacement is genuinely indicated, starts at the lowest effective dose. By the second audit there is a trend line and the conversation is about whether the dose is doing enough, not whether it can go higher. If the answer is that the lowest dose is achieving the result, the protocol stays there. Our revenue does not move either way, because the fee is flat at $299 a month and the pharmacy bills for the medication separately at its own price.

What the treatment actually involves

For men with confirmed hypogonadism, testosterone replacement therapy aims to bring levels into a healthy range where federal and state law allow and the clinician decides it is indicated. The forms vary: injections, creams, gels or pellet implants and the choice depends on your preference, your labs and your clinician's judgment. What does not vary is the monitoring. Hematocrit, estradiol, PSA where appropriate and a repeated hormone panel, four times a year, with every result in your hands.

The trial evidence on safety has matured. The TRAVEL trial, published in 2023, followed more than 5,000 men with preexisting or high cardiovascular risk and found that testosterone replacement therapy did not increase major cardiac events compared with placebo. The Testosterone Trials reported that replacement in older men with confirmed low levels was associated with improvements in sexual function and some measures of mood and bone density over a year of treatment. Neither trial is a promise of safety or benefit for any individual and a clinician still rules out prostate cancer and uncontrolled heart failure before prescribing. Together they are an argument against two wrong reflexes at once. The old one that testosterone therapy is automatically dangerous and the newer one that it is automatically harmless.

The dose conversation nobody else will have with you

What makes our version different from the clinic model is not the medication. It is what happens at the second audit.

If your lowest effective dose is producing the result, the protocol stays there. The fee is $299 a month and the pharmacy bills for the medication separately, so nothing in our revenue changes with the dose. That neutrality is the point. A clinic whose revenue is the prescription has a reason to let the dose climb and a patient whose bill never changes has no reason to care about the number except for what it does clinically. We have put the incentive on the clinical side of the line, where it belongs.

Dose minimization with outcome maximization is the standing protocol. The least medicine that gets you the most result, guided by a panel that repeats every 90 days, prescribed by a clinician who has no financial stake in the dose.

Who should not pursue this

If you want testosterone as a performance enhancer or a fat-loss shortcut with normal labs, the answer is no and we would rather lose the sale than prescribe against the evidence. If you have active prostate cancer, untreated severe sleep apnea or elevated hematocrit, therapy may be contraindicated and the audit is how we find out before anything is prescribed.

If your symptoms are real, your interest is genuine and you want a clinician rather than a subscription, the eligibility check is the first step. It takes a few minutes, a clinician reviews every application and you are never charged unless a clinician accepts you into care.

Frequently Asked Questions

How do I know if my testosterone is actually low?

Symptoms alone do not make a diagnosis and neither does one reading. The threshold is symptoms plus confirmed labs, drawn in the morning, plus a clinician ruling out other causes such as sleep apnea, thyroid dysfunction or medication effects.

Will I be on testosterone forever?

That depends on your labs and your clinician's judgment. If a reversible cause is driving the level, addressing that cause may help. If genuine replacement is indicated, your clinician aims for the lowest effective dose and re-measures every 90 days.

Is testosterone therapy safe for the heart?

The TRAVEL trial, published in 2023, followed more than 5,000 men at elevated cardiovascular risk and found no increase in major cardiac events compared with placebo. Individual risk still needs a clinician's assessment before prescribing.

Is this included in the $299 membership?

The clinical relationship and the quarterly Biomarker Audit are. Medication is a separate charge billed by your pharmacy at pharmacy cost, with no markup from us.

Will my fee rise if my dose rises?

No. The fee is flat at $299 a month whatever is prescribed and whatever the dose. There is no dose upcharge and no molecule upcharge.

Do you prescribe to women?

A clinician decides when the clinical picture warrants it. Testosterone therapy in women is a different clinical question with different dosing and our protocols treat it as such. Our care addresses situations, not genders.

What if my symptoms are mostly fatigue and low mood?

Then the panel matters even more, because fatigue and low mood have many causes and low testosterone is only one of them. The panel exists to help find which cause is operating before anything is prescribed.

What the second audit answers

Because the first audit establishes and the second one decides, the 90-day follow-up deserves its own description.

By the second panel, the trend line exists. If replacement started, the level, the hematocrit and the estradiol are all visible as movements rather than single points and the conversation is about whether the lowest effective dose is achieving the result. If it is, the protocol stays there and the fee does not change either way because the pharmacy bills separately and our revenue does not move with the dose.

If the symptoms improved but the markers did not or the markers improved but the symptoms did not, that discrepancy is itself clinical information. Your clinician may broaden the search when there is a reason, for example with sleep apnea screening, thyroid antibodies or metabolic markers, billed by the lab at its own rates. The point of the cadence is that the protocol is allowed to be wrong in the first quarter, because the second one corrects it.

And if the honest reading is that testosterone was never the problem, the protocol ends rather than continuing by default. A practice whose revenue is the prescription has little reason to reach that outcome. Ours is the relationship, so the honest ending is available.

That is the whole difference in one audit. The clinic model asks whether the subscription renewed. The measured one asks whether the dose is still earning its place and the flat fee is what makes the second question possible to answer honestly.

One last thing

The clinic down the street wants you on the highest dose forever. The standard system wants you dismissed. Both are avoiding the actual work: measuring what is wrong and prescribing the least medicine that fixes it. That work is the membership and the flat fee is what keeps it honest.

Related Guides

• Hormone optimization: the complete guide
• Low testosterone: when in range is not right
• What a Biomarker Audit includes
• Who the membership is and is not for

References

1. Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline. 2018. doi.org/10.1210/jc.2018-00229